HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

JMS Bartlett, I Ahmed, MM Regan, I Sestak, EA Mallon, P Dell'Orto, B Thurlimann, Caroline Seynaeve, H Putter, CJH van de Velde, CL Brookes, JF Forbes, G Viale, J Cuzick, M Dowsett, DW Rea

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)129-138
Number of pages10
JournalEuropean Journal of Cancer
Volume79
DOIs
Publication statusPublished - 2017

Cite this